Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Autoriseret fysioterapeut Dorte Nielsen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   9.7% 7.3% 6.4% 6.2% 7.4% 8.9% 11.5% 11.5%   Credit score (0-100)   27 33 36 37 32 28 21 21   Credit rating   BB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -4.6 625 560 511 501 519 0.0 0.0   EBITDA   -4.6 541 29.3 -20.8 56.3 92.6 0.0 0.0   EBIT   -4.6 466 -45.7 -95.8 -18.7 17.6 0.0 0.0   Pre-tax profit (PTP)   58.0 480.1 -5.5 -73.0 -17.2 37.9 0.0 0.0   Net earnings   59.1 381.9 -15.4 -48.8 -10.0 37.2 0.0 0.0   Pre-tax profit without non-rec. items   58.0 480 -5.5 -73.0 -17.2 37.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   219 601 585 437 426 464 259 259   Interest-bearing liabilities   78.0 439 426 457 471 303 116 116   Balance sheet total (assets)   300 1,308 1,123 943 990 848 375 375   Net Debt   -26.2 126 239 364 294 207 116 116     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -4.6 625 560 511 501 519 0.0 0.0   Gross profit growth   26.6% 0.0% -10.4% -8.8% -1.8% 3.6% -100.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   300 1,308 1,123 943 990 848 375 375   Balance sheet change%   26.8% 335.4% -14.1% -16.0% 5.0% -14.3% -55.8% 0.0%   Added value   -4.6 540.7 29.3 -20.8 56.3 92.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 600 -150 -150 -150 -150 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 -2.0 -3.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 74.5% -8.2% -18.8% -3.7% 3.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.7% 62.1% 1.2% -5.7% -0.3% 5.7% 0.0% 0.0%   ROI %   22.0% 74.4% 1.4% -6.1% -0.3% 6.3% 0.0% 0.0%   ROE %   31.2% 93.2% -2.6% -9.5% -2.3% 8.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   72.9% 45.9% 52.1% 46.3% 43.1% 54.7% 69.0% 69.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   569.3% 23.3% 815.5% -1,747.0% 522.4% 223.4% 0.0% 0.0%   Gearing %   35.7% 73.1% 72.8% 104.7% 110.5% 65.3% 44.9% 44.9%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.5% 7.6% 4.7% 3.3% 3.1% 3.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.3 0.6 0.5 0.3 0.5 0.5 0.0 0.0   Current Ratio   1.3 0.6 0.5 0.3 0.5 0.5 0.0 0.0   Cash and cash equivalent   104.3 312.6 186.9 93.7 177.1 95.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   24.6 -265.4 -236.3 -334.3 -265.1 -187.5 -58.1 -58.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 541 29 -21 56 93 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 541 29 -21 56 93 0 0   EBIT / employee   0 466 -46 -96 -19 18 0 0   Net earnings / employee   0 382 -15 -49 -10 37 0 0